A Review on Breast Cancer: A Global Risk Factor and Preventive Measures

Abstract

Breast cancer is a matter of global concern due to its widespread occurrence worldwide. The concerning rise in breast cancer cases highlights the need to address the disease on multiple fronts. This requires a comprehensive approach, starting with rigorous cancer screening or cancer registry, and extending to effective methods of diagnosis and treatment. Breast cancer is characterized by significant variability in both its appearance and molecular characteristics, necessitating diverse treatment regimens tailored to specific molecular subtypes. Consequently, breast cancer patients with different subtypes can expect distinct clinical outcomes. The heterogeneity of breast cancer underscores the importance of advanced molecular testing, which enables timely diagnosis and improved chances of survival. Emerging fields like artificial intelligence and liquid biopsy hold promise in unraveling the complexities of breast cancer and determining the most appropriate treatment strategies. In this review, we have explored various risk factors and cutting-edge technologies available for diagnosing breast cancer, with the aim of addressing the challenges associated with this disease and enhancing breast cancer management.Breast cancer is a matter of global concern due to its widespread occurrence worldwide. The concerning rise in breast cancer cases highlights the need to address the disease on multiple fronts. This requires a comprehensive approach, starting with rigorous cancer screening or cancer registry, and extending to effective methods of diagnosis and treatment. Breast cancer is characterized by significant variability in both its appearance and molecular characteristics, necessitating diverse treatment regimens tailored to specific molecular subtypes. Consequently, breast cancer patients with different subtypes can expect distinct clinical outcomes. The heterogeneity of breast cancer underscores the importance of advanced molecular testing, which enables timely diagnosis and improved chances of survival. Emerging fields like artificial intelligence and liquid biopsy hold promise in unraveling the complexities of breast cancer and determining the most appropriate treatment strategies. In this review, we have explored various risk factors and cutting-edge technologies available for diagnosing breast cancer, with the aim of addressing the challenges associated with this disease and enhancing breast cancer management.Breast cancer is a matter of global concern due to its widespread occurrence worldwide. The concerning rise in breast cancer cases highlights the need to address the disease on multiple fronts. This requires a comprehensive approach, starting with rigorous cancer screening or cancer registry, and extending to effective methods of diagnosis and treatment. Breast cancer is characterized by significant variability in both its appearance and molecular characteristics, necessitating diverse treatment regimens tailored to specific molecular subtypes. Consequently, breast cancer patients with different subtypes can expect distinct clinical outcomes. The heterogeneity of breast cancer underscores the importance of advanced molecular testing, which enables timely diagnosis and improved chances of survival. Emerging fields like artificial intelligence and liquid biopsy hold promise in unraveling the complexities of breast cancer and determining the most appropriate treatment strategies. In this review, we have explored various risk factors and cutting-edge technologies available for diagnosing breast cancer, with the aim of addressing the challenges associated with this disease and enhancing breast cancer management.Breast cancer is a matter of global concern due to its widespread occurrence worldwide. The concerning rise in breast cancer cases highlights the need to address the disease on multiple fronts. This requires a comprehensive approach, starting with rigorous cancer screening or cancer registry, and extending to effective methods of diagnosis and treatment. Breast cancer is characterized by significant variability in both its appearance and molecular characteristics, necessitating diverse treatment regimens tailored to specific molecular subtypes. Consequently, breast cancer patients with different subtypes can expect distinct clinical outcomes. The heterogeneity of breast cancer underscores the importance of advanced molecular testing, which enables timely diagnosis and improved chances of survival. Emerging fields like artificial intelligence and liquid biopsy hold promise in unraveling the complexities of breast cancer and determining the most appropriate treatment strategies. In this review, we have explored various risk factors and cutting-edge technologies available for diagnosing breast cancer, with the aim of addressing the challenges associated with this disease and enhancing breast cancer management.